HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lubna Nasir Selected Research

Gal-VP16

12/2009A novel two-step transcriptional activation system for gene therapy directed toward epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lubna Nasir Research Topics

Disease

5Neoplasms (Cancer)
01/2013 - 07/2004
1Infections
10/2009
1Hyperplasia
02/2008
1Adenoma (Adenomas)
02/2008
1Carcinoma (Carcinomatosis)
02/2008
1Pathologic Dilatation (Ectasia)
02/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2007
1Papilloma (Papillomatosis)
03/2007
1Dermatitis
03/2007
1Carcinogenesis
07/2004
1Heart Diseases (Heart Disease)
03/2002
1Necrosis
03/2002

Drug/Important Bio-Agent (IBA)

3Telomerase (Telomerase Reverse Transcriptase)IBA
12/2009 - 07/2004
2EnzymesIBA
02/2008 - 07/2004
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2013
1Imatinib Mesylate (Gleevec)FDA Link
01/2013
1Gal-VP16IBA
12/2009
1tumor-associated transplantation antigen (TSTA)IBA
12/2009
1telomerase RNA (bTR)IBA
12/2009
1Viral ProteinsIBA
10/2009
1Carrier Proteins (Binding Protein)IBA
02/2008
1Estrogen Receptor alphaIBA
02/2008
1Viral DNAIBA
11/2007
1DNA (Deoxyribonucleic Acid)IBA
03/2007
1Interleukin-1 (Interleukin 1)IBA
03/2002
1Matrix Metalloproteinase 13IBA
03/2002
15' Untranslated Regions (5' UTR)IBA
03/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2002

Therapy/Procedure

1Therapeutics
02/2008